Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Presentation from Shareholder Day in Copenhagen, April 12, 2016

April 12, 2016

Immunovia presented by Mats Grahn, CEO